Voice of Biotecnika | Episode No – 42
In today’s world where diseases have become the best friend and continuous companion to humans for various lifestyle and environmental reasons, there is a huge need for its fast detection and treatment. Imagine the way google searches and finds information on the web, a machine searching and finding disease in your DNA or RNA. This has become real by the magnificent work done by Mammoth Biosciences.
The company which is behind the world’s first CRISPR-based disease detection platform has announced that the United States Patent and Trademark Office (USPTO) has granted the earliest priority patents for CRISPR collateral cleavage diagnostic systems.
The US Patents cover comprehensive techniques that enable Mammoth to now offer DNA and RNA detection and are the first-of-their-kind granted in CRISPR diagnostics.
Biotecnika is honored to get an opportunity to interact with Trevor Martin CEO & Cofounder of Mammoth Biosciences and understand his journey and vision for this revolutionary bioscience product.